These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30945127)

  • 1. An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values.
    Mukuria C; Rowen D; Harnan S; Rawdin A; Wong R; Ara R; Brazier J
    Appl Health Econ Health Policy; 2019 Jun; 17(3):295-313. PubMed ID: 30945127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of preference-based health-related quality of life questionnaires in spinal cord injury research.
    Whitehurst DG; Noonan VK; Dvorak MF; Bryan S
    Spinal Cord; 2012 Sep; 50(9):646-54. PubMed ID: 22641255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and Indirect Mapping of Assessment of Quality of Life - 6 Dimensions (AQoL-6D) Onto EQ-5D-5L Utilities Using Data From a Multicenter, Cross-Sectional Study of Malaysians With Chronic Heart Failure.
    Tan YJ; Ong SC
    Value Health; 2024 Dec; 27(12):1762-1770. PubMed ID: 39127252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments.
    Kwon J; Smith S; Raghunandan R; Howell M; Huynh E; Kim S; Bentley T; Roberts N; Lancsar E; Howard K; Wong G; Craig J; Petrou S
    Appl Health Econ Health Policy; 2023 Jul; 21(4):559-584. PubMed ID: 37133712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Mapping' Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases.
    Meregaglia M; Whittal A; Nicod E; Drummond M
    Pharmacoeconomics; 2020 Jun; 38(6):557-574. PubMed ID: 32152892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
    Lamu AN; Olsen JA
    Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.
    Longworth L; Yang Y; Young T; Mulhern B; Hernández Alava M; Mukuria C; Rowen D; Tosh J; Tsuchiya A; Evans P; Devianee Keetharuth A; Brazier J
    Health Technol Assess; 2014 Feb; 18(9):1-224. PubMed ID: 24524660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and quality of life: Comparing results from utility instruments and Diabetes-39.
    Chen G; Iezzi A; McKie J; Khan MA; Richardson J
    Diabetes Res Clin Pract; 2015 Aug; 109(2):326-33. PubMed ID: 26013567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.
    Parker M; Haycox A; Graves J
    Pharmacoeconomics; 2011 Aug; 29(8):719-30. PubMed ID: 21635017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping between the Roland Morris Questionnaire and generic preference-based measures.
    Khan KA; Madan J; Petrou S; Lamb SE
    Value Health; 2014 Sep; 17(6):686-95. PubMed ID: 25236992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression.
    Abdin E; Chong SA; Seow E; Tan KB; Subramaniam M
    BMC Psychiatry; 2021 Sep; 21(1):451. PubMed ID: 34517871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.
    Teckle P; McTaggart-Cowan H; Van der Hoek K; Chia S; Melosky B; Gelmon K; Peacock S
    Health Qual Life Outcomes; 2013 Dec; 11():203. PubMed ID: 24289488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Fibromyalgia and quality of life: mapping the revised fibromyalgia impact questionnaire to the preference-based instruments".
    Collado-Mateo D; Chen G; Garcia-Gordillo MA; Iezzi A; Adsuar JC; Olivares PR; Gusi N
    Health Qual Life Outcomes; 2017 May; 15(1):114. PubMed ID: 28558703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV.
    Joyce VR; Sun H; Barnett PG; Bansback N; Griffin SC; Bayoumi AM; Anis AH; Sculpher M; Cameron W; Brown ST; Holodniy M; Owens DK
    MDM Policy Pract; 2017; 2(2):2381468317716440. PubMed ID: 30288427
    [No Abstract]   [Full Text] [Related]  

  • 18. Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D).
    Goodwin E; Hawton A; Green C
    Health Qual Life Outcomes; 2019 Aug; 17(1):136. PubMed ID: 31382960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D.
    Cox IA; Campbell J; de Graaff B; Otahal P; Corte TJ; Moodley Y; Hopkins P; Macansh S; Walters EH; Palmer AJ
    Qual Life Res; 2023 Feb; 32(2):473-493. PubMed ID: 35927542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.